| 000 | 01608 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513225151.0 | ||
| 264 | 0 | _c20010202 | |
| 008 | 200102s 0 0 eng d | ||
| 022 | _a1262-3636 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLacquemant, C | |
| 245 | 0 | 0 |
_aMutation screening of the PPARalpha gene in type 2 diabetes associated with coronary heart disease. _h[electronic resource] |
| 260 |
_bDiabetes & metabolism _cNov 2000 |
||
| 300 |
_a393-401 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAmino Acid Substitution |
| 650 | 0 | 4 |
_aCoronary Disease _xcomplications |
| 650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xepidemiology |
| 650 | 0 | 4 |
_aDiabetic Angiopathies _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Testing |
| 650 | 0 | 4 | _aGenetic Variation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIndia _xethnology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMauritius |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aPolymorphism, Restriction Fragment Length |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 |
_aReceptors, Cytoplasmic and Nuclear _xgenetics |
| 650 | 0 | 4 |
_aTranscription Factors _xgenetics |
| 650 | 0 | 4 | _aWhite People |
| 700 | 1 | _aLepretre, F | |
| 700 | 1 | _aPineda Torra, I | |
| 700 | 1 | _aManraj, M | |
| 700 | 1 | _aCharpentier, G | |
| 700 | 1 | _aRuiz, J | |
| 700 | 1 | _aStaels, B | |
| 700 | 1 | _aFroguel, P | |
| 773 | 0 |
_tDiabetes & metabolism _gvol. 26 _gno. 5 _gp. 393-401 |
|
| 999 |
_c11059687 _d11059687 |
||